“Were Women Studied?” audit
Labor induction and augmentation trials with oxytocin
Oxytocin labor trials enrolled pregnant people; sex analyses are not applicable.
Representation grade
Target population represented
Sex-analysis grade
No interpretable sex analysis
Target population represented with useful denominator detail
Basis: Trials enrolled pregnant populations for obstetric indications.
Women included but no interpretable sex analysis
Population and enrollment
Enrollment breakdown
Terminology in source: Trial reports generally describe pregnant women or pregnant people.
0%
women / female participants
0 of 0 enrolled
Inclusion and exclusion by life stage
Sex-analysis plan and findings
Missing data and generalizability limits
Specific obstetric subgroups, delivery settings, and dosing protocols vary across studies.
Findings apply to obstetric populations meeting each trial's inclusion criteria and may not generalize to all pregnancies.
Sources
Primary records
- regulatory label
Gateway to current FDA-approved prescribing information. Confirm the exact product label before clinical use.
Medical disclaimer: Her Health Peptides publishes educational, source-linked summaries. We do not provide individualized medical advice, diagnosis, or treatment recommendations. Always talk with a licensed clinician about your specific situation, especially if you are pregnant, breastfeeding, planning pregnancy, or taking other medicines.